Overexpression of the α2-adrenergic receptor on the β-cells is known to impair insulin granule docking at the plasma membrane, reduce β-cell exocytosis and insulin secretion, and increase type 2 diabetes risk (Rosengren et al., 2010). This evidence concerns the gene INS and type 2 diabetes mellitus.